N-[(2R,3R,6R,8R,10R,13Z)-9-[(2S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-13-[(E)-3-phenylprop-2-enylidene]-4,11,15-trioxabicyclo[8.5.4]nonadecan-17-ylidene]propanamide

C44H66N2O10 — CID 10395458

IUPACN-[(2R,3R,6R,8R,10R,13Z)-9-[(2S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-13-[(E)-3-phenylprop-2-enylidene]-4,11,15-trioxabicyclo[8.5.4]nonadecan-17-ylidene]propanamide
SMILESCCC(=O)/N=C1\C(C)C[C@@]2(C)OC/C(=C\C=C\c3ccccc3)COC(C1C)[C@](C)(O)[C@@H](CC)OC(=O)[C@H](C)C(=O)[C@H](C)C2O[C@@H]1O[C@H](C)C[C@H](N(C)C)C1O
InChIInChI=1S/C44H66N2O10/c1-12-34-44(9,51)40-28(5)36(45-35(47)13-2)26(3)23-43(8,53-25-32(24-52-40)21-17-20-31-18-15-14-16-19-31)39(29(6)37(48)30(7)41(50)55-34)56-42-38(49)33(46(10)11)22-27(4)54-42/h14-21,26-30,33-34,38-40,42,49,51H,12-13,22-25H2,1-11H3/b20-17+,32-21-,45-36+/t26?,27-,28?,29+,30-,33+,34-,38?,39?,40?,42+,43-,44-/m1/s1
InChIKeyVNPUKLJJEMVVLQ-YMXSQITLSA-N
MW783.02 g/mol
LogP5.58
Rot. Bonds7

About N-[(2R,3R,6R,8R,10R,13Z)-9-[(2S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-13-[(E)-3-phenylprop-2-enylidene]-4,11,15-trioxabicyclo[8.5.4]nonadecan-17-ylidene]propanamide

N-[(2R,3R,6R,8R,10R,13Z)-9-[(2S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-13-[(E)-3-phenylprop-2-enylidene]-4,11,15-trioxabicyclo[8.5.4]nonadecan-17-ylidene]propanamide (PubChem CID 10395458) has the molecular formula C44H66N2O10 and a molecular weight of 783.02 g/mol. Its IUPAC name is N-[(2R,3R,6R,8R,10R,13Z)-9-[(2S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-13-[(E)-3-phenylprop-2-enylidene]-4,11,15-trioxabicyclo[8.5.4]nonadecan-17-ylidene]propanamide.

Molecular Properties

Compound NameN-[(2R,3R,6R,8R,10R,13Z)-9-[(2S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-13-[(E)-3-phenylprop-2-enylidene]-4,11,15-trioxabicyclo[8.5.4]nonadecan-17-ylidene]propanamide
PubChem CID10395458
Molecular FormulaC44H66N2O10
Molecular Weight783.02 g/mol
Exact Mass782.47
IUPAC NameN-[(2R,3R,6R,8R,10R,13Z)-9-[(2S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-13-[(E)-3-phenylprop-2-enylidene]-4,11,15-trioxabicyclo[8.5.4]nonadecan-17-ylidene]propanamide
SMILESCCC(=O)/N=C1\C(C)C[C@@]2(C)OC/C(=C\C=C\c3ccccc3)COC(C1C)[C@](C)(O)[C@@H](CC)OC(=O)[C@H](C)C(=O)[C@H](C)C2O[C@@H]1O[C@H](C)C[C@H](N(C)C)C1O
InChIInChI=1S/C44H66N2O10/c1-12-34-44(9,51)40-28(5)36(45-35(47)13-2)26(3)23-43(8,53-25-32(24-52-40)21-17-20-31-18-15-14-16-19-31)39(29(6)37(48)30(7)41(50)55-34)56-42-38(49)33(46(10)11)22-27(4)54-42/h14-21,26-30,33-34,38-40,42,49,51H,12-13,22-25H2,1-11H3/b20-17+,32-21-,45-36+/t26?,27-,28?,29+,30-,33+,34-,38?,39?,40?,42+,43-,44-/m1/s1
InChIKeyVNPUKLJJEMVVLQ-YMXSQITLSA-N
XLogP5.58
TPSA153.42 Ų
H-Bond Donors2
H-Bond Acceptors11
Rotatable Bonds7
Heavy Atoms56
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500783.02
LogP ≤ 55.58
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}

Analyze N-[(2R,3R,6R,8R,10R,13Z)-9-[(2S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-13-[(E)-3-phenylprop-2-enylidene]-4,11,15-trioxabicyclo[8.5.4]nonadecan-17-ylidene]propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(2R,3R,6R,8R,10R,13Z)-9-[(2S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-13-[(E)-3-phenylprop-2-enylidene]-4,11,15-trioxabicyclo[8.5.4]nonadecan-17-ylidene]propanamide?
The IUPAC name of N-[(2R,3R,6R,8R,10R,13Z)-9-[(2S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-13-[(E)-3-phenylprop-2-enylidene]-4,11,15-trioxabicyclo[8.5.4]nonadecan-17-ylidene]propanamide (CID 10395458) is N-[(2R,3R,6R,8R,10R,13Z)-9-[(2S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-13-[(E)-3-phenylprop-2-enylidene]-4,11,15-trioxabicyclo[8.5.4]nonadecan-17-ylidene]propanamide.
What is the SMILES notation for N-[(2R,3R,6R,8R,10R,13Z)-9-[(2S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-13-[(E)-3-phenylprop-2-enylidene]-4,11,15-trioxabicyclo[8.5.4]nonadecan-17-ylidene]propanamide?
The canonical SMILES for N-[(2R,3R,6R,8R,10R,13Z)-9-[(2S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-13-[(E)-3-phenylprop-2-enylidene]-4,11,15-trioxabicyclo[8.5.4]nonadecan-17-ylidene]propanamide is CCC(=O)/N=C1\C(C)C[C@@]2(C)OC/C(=C\C=C\c3ccccc3)COC(C1C)[C@](C)(O)[C@@H](CC)OC(=O)[C@H](C)C(=O)[C@H](C)C2O[C@@H]1O[C@H](C)C[C@H](N(C)C)C1O.
What is the InChIKey of N-[(2R,3R,6R,8R,10R,13Z)-9-[(2S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-13-[(E)-3-phenylprop-2-enylidene]-4,11,15-trioxabicyclo[8.5.4]nonadecan-17-ylidene]propanamide?
The InChIKey is VNPUKLJJEMVVLQ-YMXSQITLSA-N. The full InChI is InChI=1S/C44H66N2O10/c1-12-34-44(9,51)40-28(5)36(45-35(47)13-2)26(3)23-43(8,53-25-32(24-52-40)21-17-20-31-18-15-14-16-19-31)39(29(6)37(48)30(7)41(50)55-34)56-42-38(49)33(46(10)11)22-27(4)54-42/h14-21,26-30,33-34,38-40,42,49,51H,12-13,22-25H2,1-11H3/b20-17+,32-21-,45-36+/t26?,27-,28?,29+,30-,33+,34-,38?,39?,40?,42+,43-,44-/m1/s1.
What are the key properties of N-[(2R,3R,6R,8R,10R,13Z)-9-[(2S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-13-[(E)-3-phenylprop-2-enylidene]-4,11,15-trioxabicyclo[8.5.4]nonadecan-17-ylidene]propanamide?
N-[(2R,3R,6R,8R,10R,13Z)-9-[(2S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-13-[(E)-3-phenylprop-2-enylidene]-4,11,15-trioxabicyclo[8.5.4]nonadecan-17-ylidene]propanamide has a molecular weight of 783.02 g/mol, XLogP of 5.58, 7 rotatable bonds, 2 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(2R,3R,6R,8R,10R,13Z)-9-[(2S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-13-[(E)-3-phenylprop-2-enylidene]-4,11,15-trioxabicyclo[8.5.4]nonadecan-17-ylidene]propanamide is sourced from PubChem (CID 10395458), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).